首页 › 基金 › Legato Capital Management LLC › ADPT
Legato Capital Management LLC 对 ADPT 的持仓历史
ADAPTIVE BIOTECHNOLOGIES COR · 医疗保健
Legato Capital Management LLC 在 Q3 2026 的 13F 申报中披露持有 ADPT(ADAPTIVE BIOTECHNOLOGIES COR)186,910 股,市值约 US$5.4M,约占其申报组合的 0.52%,在其申报持仓中市值排名第 24 位。 Legato Capital Management LLC 最近 13 个申报季度中有 13 个季度披露了 ADPT 持仓,最早可追溯至 Q3 2023。
最后更新: 2026-11-13 · 来源: SEC EDGAR Form 13F-HR
Legato Capital Management LLC 对 ADPT 的持仓演变
Legato Capital Management LLC 于 Q3 2023 首次披露 ADPT 持仓:97,494 股(约 US$531K)。 该持仓在 Q2 2026 达到峰值 273,441 股,市值约 US$5.9M。 在 13 次申报中,Legato Capital Management LLC 5 次增持、4 次减持、3 次保持不变。 最近一期申报(Q3 2026)显示持股 186,910 股、市值约 US$5.4M,环比减持 -86,531 股。。 持仓曾出现大幅变动:Q2 2024 增持约 64% (随后一个季度股价上涨 41%)、Q1 2026 减持约 36% (随后一个季度股价上涨 55%)、Q2 2026 增持约 79% (随后一个季度股价上涨 35%)。
逐季持仓明细
| 季度 | 股数 | 金额 | 变化 |
|---|---|---|---|
| Q3 2023 | 97.49K | $531.34K | 新进 |
| Q4 2023 | 128.05K | $627.47K | 增持 |
| Q1 2024 | 128.05K | $411.05K | 持有 |
| Q2 2024 | 209.70K | $759.12K | 增持 |
| Q3 2024 | 241.36K | $1.24M | 增持 |
| Q4 2024 | 184.67K | $1.11M | 减持 |
| Q1 2025 | 182.45K | $1.36M | 减持 |
| Q2 2025 | 182.03K | $2.12M | 持有 |
| Q3 2025 | 238.01K | $3.56M | 增持 |
| Q4 2025 | 238.61K | $3.87M | 持有 |
| Q1 2026 | 152.34K | $2.11M | 减持 |
| Q2 2026 | 273.44K | $5.87M | 增持 |
| Q3 2026 | 186.91K | $5.40M | 减持 |
折线上的点按变动类型着色;缺失季度表示该季未申报持仓。
关于 ADPT 与 13F 数据
ADPT(ADAPTIVE BIOTECHNOLOGIES COR)属于医疗保健行业。我们追踪的基金中还有 58 只申报持有 ADPT,申报仓位最大的包括:维京环球投资 (US$643.4M), VIKING GLOBAL INVESTORS LP (US$643.4M), Aristotle Atlantic Partners, LLC (US$39.4M)。 根据美国 SEC 规定,管理资产超过 1 亿美元的机构投资者须在每季度结束后 45 天内提交 13F 表,披露其美股多头持仓。该数据不包含空头、大部分期权及海外持仓,因此应将其视为季度快照而非实时仓位。
其它持有 ADPT 的基金
- 维京环球投资 29.99M 股 · $643.37M · Q2 2026
- VIKING GLOBAL INVESTORS LP 29.99M 股 · $643.37M · Q2 2026
- Aristotle Atlantic Partners, LLC 1.84M 股 · $39.44M · Q2 2026
- PERCEPTIVE ADVISORS LLC 1.22M 股 · $26.11M · Q2 2026
- Blue Water Life Science Advisors, LP 1.01M 股 · $21.67M · Q2 2026
- Granite Investment Partners, LLC 628.10K 股 · $18.15M · Q3 2026
- NEXT CENTURY GROWTH INVESTORS LLC 622.89K 股 · $18.00M · Q3 2026
- Hillsdale Investment Management Inc. 551.35K 股 · $15.93M · Q3 2026
更多关于 Legato Capital Management LLC
常见问题
How long has Legato Capital Management LLC held ADPT?
Legato Capital Management LLC has disclosed ADPT holdings in 13 of the last 13 reported quarters, going back to Q3 2023.
What is Legato Capital Management LLC's current position in ADPT?
As of Q3 2026, Legato Capital Management LLC holds 186.91K shares of ADPT (ADAPTIVE BIOTECHNOLOGIES COR), valued at $5.40M, representing 0.52% of its reported portfolio and ranking #24.
Has Legato Capital Management LLC been buying or selling ADPT?
In the latest 13F filing (Q3 2026), Legato Capital Management LLC reduced its position in ADPT. The position peaked in Q2 2026 at 273.44K shares.
Which other funds hold ADPT?
Other major institutional holders of ADPT include 维京环球投资, VIKING GLOBAL INVESTORS LP, Aristotle Atlantic Partners, LLC, among 58 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.